Copley Acquisition Corp (NYSE: COPL) and Ignite Proteomics Announce Business Combination Agreement to Advance Precision Oncology
Copley Acquisition Corp (NYSE: COPL), a SPAC, has entered into a definitive business combination agreement with Ignite Proteomics, a precision oncology company specializing in pathway-level protein analytics. The combined entity, Ignite Proteomics Holdings, Inc., plans to list on the New York Stock Exchange with a pro forma enterprise value of $150…